Coriolis Pharma Is A Global Contract Research And Development Organization Specializing In Biologicsincluding Gene And Cell Therapiesvaccinesand Advanced Therapy Medicinal Productsfounded As A Spinout From Ludwig Maximilians University In Munichthe Company Provides Comprehensive Support For Drug Product Developmentanalytical Servicesand Manufacturing Across All Phases Of Biopharmaceutical Development The Company Focuses On Formulation Developmentlyophilization Technologiesand Analytics For Biologics Such As Proteinspeptidesnucleic Acidsand Viral Vectorscoriolis Pharma Operates Facilities With Biosafety Level 2 Certificationallowing It To Work With Sensitive Biologicsits Services Include Formulation Optimizationmethod Developmentand Non Gmp Manufacturingas Well As Gmp Process Development For Commercial Scale Productionwith A Recent Expansion Into The U Smarketcoriolis Pharma Aims To Enhance Support For North American Clients And Facilitate Transitions From Preclinical To Clinical Stages
United States
Germany
